ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000881.1|Toyocamycin_1 # 2 # 2830 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.773	BGC0000881.1|Toyocamycin_1 	2	2830	+	Loose	470	37.3502	sdiA	32.39	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	AACGAGTTGCGCCGGCTCGGCGCGGCCCTGGAAGACGGCGCGCACGGCGGGACCGTCCGCGCCCTGGTCACCGGCGAACCGGGCATCGGCCGGACCACCCTGCTCCAGGCGTGCGCGGCCGCGGCCCGCGCCCGGGGCTGGATCACCGTCGAGGTGCGGTGCCCGCCGCACGAACACCTGCCGCCGTTCGGCCTCGCCCGGCACCTCGCGGGCCGACTGGCCGCGTTGCTGCCGCCGGAGCACCCCCGCCGCACCGCGCTCGACGCCGTCGCGCACCCGCCGGCCGACCGCACCGGACCGGCCGACCCGACGCCGGTGGCGGCGGACGTGGTGCTGGGCCACGTCAGGGCGGCCCTCACCGTGCTGACCGCCGGCGCACCCGTGCTCCTCGGCCTCGACGACGCCCACCGGGCCGACGCCGCCTCGCTGGACTTCCTGCACCGGGCCCTGCTCGCCCCGCCGCTCGCCCGCGTCGTCCTGGTCGCCTCCGCCCGGGACGGCGAGAACCGCAGCGGCGGCGGCCCCGGCACACTGCCCGAACTCCTCGCCGGCGCACGGCAACTGCCGCTCACCGGGCTGGCCCCGTCCCAGTCCGCGGCGTTGCTCCGCAGGGTCGCCCGCCGGGCACCGGCCCCCGACGTCGCCGCGGAGTGCCACCGCGCCTGTGCCGGCAACCCCGCCCTCCTCACCGAAGTCGCCCGGGTGCTGCGCGAGCGGCCGGCGGATCGCGCCGGTGCGCCGCTGGCCGCCGCACTGCGGCCCGCGGCCGTCGCGGAACTGATCGGCACCCGGCTGGCCGGACTCGATCCGAACGCCGGCAAGGTCGCCCTGGCCATCGCCGTCGCGGAGACCCACTCCGCAGCCGAGCCCCTGCTCGTCTCCCACCTCAGCGGGCTGACCCTGGCCGAAACCCTGGCCGCGGTCGACCTGTTGGTGTGCATGCACCTGGTCGCCGACGACGACACGCTGTACCTGCGCCACCGCGTCGTGCGCGAGGCGCTGCTGGGCCGGATGACGCTGATGGCCCGCAACGCCGCCCACCTCGCGGCCGCCACCCACCTGCACGGCAAGCAGGCGCCCGCCGACCGGATCGCCGACCACCTCGCGGCGTCGACGGTGACCCTGGACGAGCCGTGGGCCGCCCCCGTGCTGCTGCGGGCCGGGCAGAAGGCCCTCGCGGCCCGGGAACCGCAACGGGCCCGGCGCTATCTGGCGCACGCCGTACGCGCGGCGTCGGGCGCGGACCGCCGGACCGCGGTGCTGGAGCTCGTCGACGCCGAGATCGGCATCGACCTGCAAGCGGGGCTGCGGGAGGCGGTCCGGACCCTGGAGGAGACCACCGAGGACGCCCTCCGGCTCCCGCTGCTGGCCAGGATCAGCACCGCGCGCTACCTCGGAACCGACCCCGGCGCGACCGCCCGGACGACGCCCGCCCCGGACTACGCCCGGCCCGACTGGCATCCCGTGCACGCCCTGCTCGACGGCCTGGCCGCCTACCCGCTGCCGGACACCGCCCGACGCACCGGGGAGCGCCTCGCGCCCGAGGAGCCCGGGCCGGGGTGCCCCGAGACCGGCGGGGCCGACTGCTGCGGCGCGGACCGGGCCGCCGCAGACGCCGTCGTGCGCGCCCTGCGCAGCCACCTGACGTGTCGGCCGGCCGACGCGGTGCACGGCGCGCGGGAGGCGTTGCGGGCGGAGGGCGGACTGTGCCTGCACCCGGTGCTCCGGCTGATGGCGCTGATGATCCTCGCCTGGAACGGCCGCGACGCCGACGTGACGTCCCACCTGCGGCTCCACCACGACTGCGGGCACTGCCACGCGCACCCGCTGCACCGGGCCCTGCTGCTGCCGGTCACCGCCCACCTGGCCCTGCTGCGCGGCCGGCTGCGCACCGCGCACGACCGGCTCGGCGCATCCCTCGACGCCCTGGCTCACTACGGGACCCGGCCCCAACACCCGCTGCTGATCTGGCTCGTGGGGATGCTGGCCGAGGTCCGCCTGGCCATGGGACGCGGCCCCGAGGCCCGCGCGCTGCTGCACGAACACGGCTGCCTGGACGGCCCGGCACCGGACCGACTGCACCGCGAGGTGTGGCTGACCCGGGCGAGGCTGCGGGCCGACGGCGGTGACCTGGCGGGCGTAGCGGCGGACCTGGCCGAGCTCACCGACGCCCCGGGGGGACCCACCGGCGGCGTGCACACCTACGTCCACACCGTCGATCTGCTGACGCAGGTGGGCCGGCACGTGCAGGCCCGGGAGACCGCCCGGACGCTGCTGCGGGTCGCCGAGGCCATGGGCACACCGCGGGAACGCGGCATCGCCCTGCGGGTGCTCGGCGCACTGGGCGGCGCCCCCGAGGGCGAGGACCTGCTGCGCGAGGCGATGCGCCTGCTGGCCGCGGCGGAGGCCGACTTCGACCTCGCGCACGCCGCCGCCGACCTGGCCCTGTTGCTGTTCGACGACGGGCGCTACGAGGAGGCGACGGCGGAGCTGAGCACGGCGCTGGAGCTGGCGGACCGGTGCGGCGCCCGACCGCTCGCGCTGCGGGTGCGGCAGCGGCTCGCCGCCGCGGAGGGGCGCTCCGCCGACCGGTCGCCGCTGGGCGGCGTGCTGAAGCTGACCAAGCGGGAGAAGCAGATCCTCATCGACGCCGTGCGCGGCTCGACCAACGAACGGATCGCGACGACCCTGCACATCACCCGCCGCACGGTCGAACTCCACCTGTCCAGTGCGTACCGCAAGCTCGACATCACCGGCCGCAAGGACTTCCCGCACCTGTTCCGGACCGCGGGGCTGTGGCCGCTGCTGGTCGATTCCGCCGCCACCTGA	NELRRLGAALEDGAHGGTVRALVTGEPGIGRTTLLQACAAAARARGWITVEVRCPPHEHLPPFGLARHLAGRLAALLPPEHPRRTALDAVAHPPADRTGPADPTPVAADVVLGHVRAALTVLTAGAPVLLGLDDAHRADAASLDFLHRALLAPPLARVVLVASARDGENRSGGGPGTLPELLAGARQLPLTGLAPSQSAALLRRVARRAPAPDVAAECHRACAGNPALLTEVARVLRERPADRAGAPLAAALRPAAVAELIGTRLAGLDPNAGKVALAIAVAETHSAAEPLLVSHLSGLTLAETLAAVDLLVCMHLVADDDTLYLRHRVVREALLGRMTLMARNAAHLAAATHLHGKQAPADRIADHLAASTVTLDEPWAAPVLLRAGQKALAAREPQRARRYLAHAVRAASGADRRTAVLELVDAEIGIDLQAGLREAVRTLEETTEDALRLPLLARISTARYLGTDPGATARTTPAPDYARPDWHPVHALLDGLAAYPLPDTARRTGERLAPEEPGPGCPETGGADCCGADRAAADAVVRALRSHLTCRPADAVHGAREALRAEGGLCLHPVLRLMALMILAWNGRDADVTSHLRLHHDCGHCHAHPLHRALLLPVTAHLALLRGRLRTAHDRLGASLDALAHYGTRPQHPLLIWLVGMLAEVRLAMGRGPEARALLHEHGCLDGPAPDRLHREVWLTRARLRADGGDLAGVAADLAELTDAPGGPTGGVHTYVHTVDLLTQVGRHVQARETARTLLRVAEAMGTPRERGIALRVLGALGGAPEGEDLLREAMRLLAAAEADFDLAHAAADLALLLFDDGRYEEATAELSTALELADRCGARPLALRVRQRLAAAEGRSADRSPLGGVLKLTKREKQILIDAVRGSTNERIATTLHITRRTVELHLSSAYRKLDITGRKDFPHLFRTAGLWPLLVDSAAT	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	392.50	gnl|BL_ORD_ID|207|hsp_num:0	228			459	669	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000881.1|Toyocamycin_3 # 3806 # 4504 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000881.1|Toyocamycin_3 	3806	4504	-	Loose	400	25.409	catB2	27.27	3002675	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGTTGAGGAAATGGGTCGGACAGGGCGGACCACGGTCGTGCTGGACCGGGACGGCACCCTGTTGGACTTCTACGAGATGTTCCACCGCTTCGTCCTGGACCTCCACCGGCAGGAGGGGGTGATTCCGCCGCCCCGCGAGGAGATCCTCGGCTTCGGCTACTGGTCCTCGATCACCAGCGGGGCGCTGCACATCGGGTCGGTGCGGGTGCGGGACCGGGTCGACGAGGTGGCCCACCGGTACATGGCGCACGGCACGCTCTACCCCGGGGTGGTGCCGATGCTGTCGGCGCTGTCCGGGGCCGGGGTGCGGCTCGCGCTGGTCAGCTCCTGGGTCGGCACCGAGGCCACCGTGGCCCTGCTGGAGCGCTACGCGGTCCGCCCGTGCTTCGGCCCGATCCTGACCCGGGACGACCTGGACGCGGGGGACGGCCCGGTCTCCGACGCCGACTGCAAGACCGCGTTGGCGCGGCGGGCGTTGGACGGGCTCGGCCACGCGCCCGACCACCGGCTCTACGTCGTCGGCGACACCCCGTCGGACATCGCGTTGGGCCGCCGGTTGGGGGCCGTCGTGGTCGGGGTGCGCACCGGCAACGGCGGCGGGCTGCCGGCCGAGGGCACGCCGGAGGGGCCGGACGTCCTGCTCCCGTCGGCCGCGGACCTGGGCCGCTTGATCCTCCAGGCGGAACCGGTGGGGTGA	MVEEMGRTGRTTVVLDRDGTLLDFYEMFHRFVLDLHRQEGVIPPPREEILGFGYWSSITSGALHIGSVRVRDRVDEVAHRYMAHGTLYPGVVPMLSALSGAGVRLALVSSWVGTEATVALLERYAVRPCFGPILTRDDLDAGDGPVSDADCKTALARRALDGLGHAPDHRLYVVGDTPSDIALGRRLGAVVVGVRTGNGGGLPAEGTPEGPDVLLPSAADLGRLILQAEPVG	MTNYFESPFKGKLLTEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDQLIIGSFCSIGSGAAFIMAGNQGHRYDWVSSFPFFYMNEEPAFAKSVDAFQRAGDTVIGSDVWIGSEAMIMPGIKIGHGAVIGSRALVTKDVEPYTIVGGNPAKSIRKRFSEEEISMLLDMAWWDWPLEQIKEAMPFLCSSGIASLYRRWQGTSA	110.48	gnl|BL_ORD_ID|657|hsp_num:0	712			144	375	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000881.1|Toyocamycin_6 # 6068 # 7453 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.729	BGC0000881.1|Toyocamycin_6 	6068	7453	-	Loose	500	27.335	CTX-M-141	27.91	3001999	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGACGAACCCTTGGGAGGACGGCCGCTACGGCAGCCCGGAGATGCGCCTGCTGGTCAGCGACCGCAACCGCTACCAGCTCTTCGTACGGGTGGAGGGGGCGTTGGCCGCGGAGCAGGGCCAGTTGGGGGTGATCCCGTCCGAGGCCGCCGGGGCGATCGCCGCCCGGGCCCGCGACCACCGGTGCGACCTGGCGCGGATCGCCGAGATCGAGACGGTGAGCCGGCACGAGCTCTACGCCGTAGTCCAGCAGTTCGCCGAGACCTGCGCGCCCCACGGCCGCTACGTGCACCACGGGGTGACCAGCAGCGACGTCATCGACACCGCGCTGGCGCTCCAACTGGACGCGGCGATCGGCCTCCTGGGCGAACGGCTCGGCGTCCTGATGTCCGCGCTGTGCCGGCAGATCGCCGAGGAGGGCGGGCGGGTGATGATCGGACGGACCCACGGCCAGCACGCCCAGCCCGTCACCCTGGGGTTCAAACTCGCGGTGTTCCTCGACCAGTTGACCCGGTGCCTGGCGCGGCTGGCGGAACTGCGCGAGCGCGCCGTGCGGGGCAAGGTCGCCGGTGCGGTCGGTTCGCTGGGCGGACTGGGACCGCAGGGCATGGCGGTGCAGCGGGCGGTGCTGGCCCGGCTGGGCCTGCCGGAGCCGCAGATCTGCGCCCAGGCGGTGGCGCGGGACCGGATCGCGGAGTTCGTCTCCTGGGCCGCGCTGACCGCGGCCTGCCTGGAGAACCTCGCGACCGAGATCCGCAACCTCCAGCGGACGGAGATCGGCGAACTCGCCGAGTCCTTCGCCGAGGGGGACCAGATCGGCAGCTCCGCCATGCCGCACAAGCGCAACCCGGTGCGCAGCGAACGCATCTGCAGCCTGGCCCGGCTGCTGCGGTCGCTGGTCGGCCCCGCGTTGGAGAACGTGGTGACCTGGCACGAACGGGACCTGGCCAACTCCGCCAACGAACGCTTCACCCTGCCGCAGGCGTGCGTGCTGCTCGACGAGATGCTCCTCACCACCACCGCCGTGGTGGACGACCTGAGGGTCTTCCCCGAGCGGATGCGGGAGAACCTCGACCGGTCGCGCCACAGTCACCTCAGCGAGGCGGTGCTGCTGGCCATGGTCGACCGCGGGACGGACCGGCTCGACGCCTACCGGGCCCTGCAACGGGCCAGTGCGCTCGCCGCCCGGGACGACCGCGACCTGGTGGCGGTGCTGGCGGACGACGCGTCGGTGACCGCGGTGCTGCCCGCACCGGACCTCGCGGCCCTGGCCGAGGCGGCCGCGGACACCGGCTTCTGCGACACCCTGGCGCAGGAGACCGTGCGCCGGGCCGAGGAAGCGCTCGCACAGTCGACGGAAGGAGCTCGGACATGCCCGGCACGGTGA	MTNPWEDGRYGSPEMRLLVSDRNRYQLFVRVEGALAAEQGQLGVIPSEAAGAIAARARDHRCDLARIAEIETVSRHELYAVVQQFAETCAPHGRYVHHGVTSSDVIDTALALQLDAAIGLLGERLGVLMSALCRQIAEEGGRVMIGRTHGQHAQPVTLGFKLAVFLDQLTRCLARLAELRERAVRGKVAGAVGSLGGLGPQGMAVQRAVLARLGLPEPQICAQAVARDRIAEFVSWAALTAACLENLATEIRNLQRTEIGELAESFAEGDQIGSSAMPHKRNPVRSERICSLARLLRSLVGPALENVVTWHERDLANSANERFTLPQACVLLDEMLLTTTAVVDDLRVFPERMRENLDRSRHSHLSEAVLLAMVDRGTDRLDAYRALQRASALAARDDRDLVAVLADDASVTAVLPAPDLAALAEAAADTGFCDTLAQETVRRAEEALAQSTEGARTCPAR	MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNLTLGKALAETQREQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGSGDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF	158.42	gnl|BL_ORD_ID|974|hsp_num:0	1064			516	768	
BGC0000881.1|Toyocamycin_7 # 7450 # 8595 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.755	BGC0000881.1|Toyocamycin_7 	7450	8595	-	Loose	1000	31.5722	MCR-2.4	28.42	3007283	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGGCAGTTCGCGACATACGCACCGGGCTCAGCCTGGACGACGTCCTGCTGGTGCCCCGCCGCACCTCGGTGGTGAGCCGCTCGGCGACCGACACCAGCACCGAGCTGGCCGGGATCACCCTGCGGGTGCCGGTCCTCTCCGCCAACACCCCCTGGTGCACCGGCCGGCAGATGGCCGTCGCCATGGCGGTGGCCGGTGGGCTCGGGATCGTCCACCGCATGCAGACCGCCGAGGACCAGGCCGCGGAGGTGGCCGCGGTCAAGGCGACGCCGGTGCCCGAGGGCACGGAGCGGGCCACCGTCGACGCGCAGGGCCGGCTGCGCGCCGGGGCGGCCGTGGGGGTGACCGACGACTATCTGGAGCGGGCCGCCCGGCTCGTCGAGGCGGGCGCGGACGTCCTGGTCACCGACGTCGCCCACGGCCACGCGGACTACGTCCTGGCCTCCGTCGAGAAGCTGCGGGCCCGTTTCCCTGACACGCCGCTGATCGCCGGGAACGTCGCCACCGCCGCCGGCACGAGGGACCTGATCGAGGCCGGCGCCCACGCCGTGAAGGTGGGCATCGGCCCCGGCGGCATCTGCACCACCCGGCTCGTCGCGGGCAGCGGGGTGCCGCAGCTGACCGCGGTCCTCGACTGCGCCGAGGAGGCGGCCGGTTCCGGCGTCCCGGTGATCGCGGACGGCGGGATCAAGGCGCCGGGCGACGTCGTCAAGGCGCTGGCCGCCGGCGGCCACGCGGTGATGCTGGGCAGCGCCCTGGCCGGCGCCGACGAGAGCGCGGCCCGCCTGGTGGAACGCGACGGCGTCCCCGTGAAGGTCAGCACCGGCTTCGTGACGTTCGGCATGCAGCTGACCCTGAAGCGGGCCCGCGGCGAAGAGGTCAGCCGCGAGGAGCTGGACGCGTACACCCCCGAGGGCGTCGAGGCCACCTTCGCCCACACCGGGCCGCTGGCCGCCACCCTGCGGCCGTTCGTCGGCGGACTGCGGTCGGGCATGAGCTACTCCGGGGCGCACACCCTGGCCGAACTGCGGGCGCAGGCCGAGTTCATCCGGGTCACGCCGGCCGGACTGTCGGAGAGCCGCCCGCACGCCCTGGAGCGGACCCAGCAGGTGGCCCTGGACTACGCCCGGGAGGCCACCGGATGA	MAVRDIRTGLSLDDVLLVPRRTSVVSRSATDTSTELAGITLRVPVLSANTPWCTGRQMAVAMAVAGGLGIVHRMQTAEDQAAEVAAVKATPVPEGTERATVDAQGRLRAGAAVGVTDDYLERAARLVEAGADVLVTDVAHGHADYVLASVEKLRARFPDTPLIAGNVATAAGTRDLIEAGAHAVKVGIGPGGICTTRLVAGSGVPQLTAVLDCAEEAAGSGVPVIADGGIKAPGDVVKALAAGGHAVMLGSALAGADESAARLVERDGVPVKVSTGFVTFGMQLTLKRARGEEVSREELDAYTPEGVEATFAHTGPLAATLRPFVGGLRSGMSYSGAHTLAELRAQAEFIRVTPAGLSESRPHALERTQQVALDYAREATG	MTSHHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVALMGAMLLIVVLFSYRYVLKPVLILLLMMGAVTSYFTDTYGTVYDTTMLQNALQTDQAESKDLMNLAFFVRIIGLGVLPSIVVAWVKVDYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSVGKLASIEYKKATAPKDTIYHAKDAVQTTKPSERKPRLVVFVVGETVRADHVQFNGYSRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVDILWRDNNSDSKGVMDKLPATQYFDYKSATNNTICNTNPYNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNTSFKPTASDTALTHDAITPTLLKLFDVTAGKVKDRTAFIQ	70.82	gnl|BL_ORD_ID|4895|hsp_num:0	5888			1134	1401	colistin A; colistin B
BGC0000881.1|Toyocamycin_8 # 8630 # 9235 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.693	BGC0000881.1|Toyocamycin_8 	8630	9235	-	Loose	300	24.2534	tet(Q)	32.26	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGAGCACAGTGAGCGGAGCCCCCGAACTGGACGTCCTCGACGACTCCGGGCCGCAGGTCCCGGACCCGCTGGAGGACGTCGCGCGCAAGCTGCTGATCGAGATCGGCGAGGACCCGGAGCGCGACGGGCTCAAGGAGACGCCGGCCCGCTTCGCCCGCTGGTGGCGGGAGTTCTCCCGCTACGACGCGGGGGCGGTCGACACGCTGTTCCCCCTCCAGACGGAGGGACAACTGGTCATGGTCTCGGACATCAACGTGTGGTCGCTGTGCGAGCACCACCTGCTGCCCTTCTCCTGCTCCCTGACCATCGCCTACCGGCCCAAGGGCGACGTGCTCGGACTGTCGAAGTTCGCCCGGATCGCCCATCGCCACGCGCACCGGCTCCAGGTGCAGGAGCGCCTGGTCCGCGACATCGCGGACGAGGTCACCAAGGTGACCGGTTCGGTCGACGTCGCGGTCATCGCCACCGGCGAGCACCTGTGCATGAGCATGCGCGGCATCCGTACCCCGGCGGTCATGACGTCCACGGCCTACTCCGGGGTCTTCGAGGAGTACGGGCCGGCCCGTCAAGAGCTCGTGGCGACGGTGTTCCCGCTGCGCAAGTGA	MSTVSGAPELDVLDDSGPQVPDPLEDVARKLLIEIGEDPERDGLKETPARFARWWREFSRYDAGAVDTLFPLQTEGQLVMVSDINVWSLCEHHLLPFSCSLTIAYRPKGDVLGLSKFARIAHRHAHRLQVQERLVRDIADEVTKVTGSVDVAVIATGEHLCMSMRGIRTPAVMTSTAYSGVFEEYGPARQELVATVFPLRK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	30.59	gnl|BL_ORD_ID|1219|hsp_num:0	1183			72	252	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000881.1|Toyocamycin_9 # 9232 # 9903 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0000881.1|Toyocamycin_9 	9232	9903	-	Loose	600	27.335	cfrA	27.55	3003441	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGCAGGGAGAGGGCCCCTCGGCCGGGCAGCGGTGCGCCTTCGTGCGGTTGGGCGGCTGCAACCTGTCCTGCCGCTGGTGCGACACCCCGTACACCTGGGACTGGACCGGAGTGGGCGACTCCGGGGTCGCCTACGACCCCAAGCGGGAACTGCGGCCGATGCCGTGGACCGACGTGCTGCGCGCGCTGCTCGCCTACGAGGTACCGCTGATCGTGGTCTCCGGGGGCGAACCCCTCAGCCAGCAGCGCCGGTTGCTGCCGCTGCTGGGCGCGCTGACGGAGGCCGGCCGCAAGGTGGAGATCGAGACGAACGGCACCGTGGTGCCGCAGGACGACCTGGTGGCGCTCGGCGTGCGGTTCAACGTCTCGCCCAAGCTGTCGCACTCGGGCGATCCGCAGGCGCGGCGGATCGTGCCGGACGCGTTGCGGGCGTTCGCGGCCGTCCCGGGGACCGCCTTCAAGTTCGTCTGCCGCACCACGAGCGACCTCGACGAGGTGGCGCAGCTCGTCGACCGGTACGGGACCCGCCCGGTGTGGATCATGCCCGAGGGGCAGGTACCCGCCGAGGTCGGCCAACACCTGTCCGCGCTGGGGGACGACGTCGTGGCACGCGGCTGGAACCTGACCACTCGATTGCATGTTGCCGTCTGGGGCGACAGGAGAGGCGTGTGA	MQGEGPSAGQRCAFVRLGGCNLSCRWCDTPYTWDWTGVGDSGVAYDPKRELRPMPWTDVLRALLAYEVPLIVVSGGEPLSQQRRLLPLLGALTEAGRKVEIETNGTVVPQDDLVALGVRFNVSPKLSHSGDPQARRIVPDALRAFAAVPGTAFKFVCRTTSDLDEVAQLVDRYGTRPVWIMPEGQVPAEVGQHLSALGDDVVARGWNLTTRLHVAVWGDRRGV	MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFGETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCATGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFALSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNILDEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ	63.90	gnl|BL_ORD_ID|642|hsp_num:0	696			330	582	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
